Your browser doesn't support javascript.
Attributes of dysgeusia and anosmia of coronavirus disease 2019 (COVID-19) in hospitalized patients.
Samaranayake, Lakshman Perera; Fakhruddin, Kausar Sadia; Mohammad, Osman Elfadil; Panduwawala, Chamila; Bandara, Nihal; Ngo, Hien Chi.
  • Samaranayake LP; Faculty of Dentistry, The University of Hong Kong, Hong Kong, Hong Kong SAR, China.
  • Fakhruddin KS; Departments of Preventive and Restorative Dentistry and Oral and Craniofacial Health Sciences, University of Sharjah, Sharjah, UAE.
  • Mohammad OE; University Hospital of Sharjah, Sharjah, UAE.
  • Panduwawala C; Departments of Preventive and Restorative Dentistry and Oral and Craniofacial Health Sciences, University of Sharjah, Sharjah, UAE.
  • Bandara N; Oral Microbiology, Bristol Dental School, University of Bristol, Bristol, UK.
  • Ngo HC; Dental School, University of Western Australia, Perth, WA, Australia.
Oral Dis ; 28 Suppl 1: 891-898, 2022 Apr.
Article in English | MEDLINE | ID: covidwho-2279544
ABSTRACT

OBJECTIVES:

While chemosensory dysfunctions, dysgeusia and anosmia/hyposmia, are recognized as distinctive symptoms of COVID-19, their temporality of presentation and association with the patient age, gender, disease severity, and comorbidities has been sparsely studied. Hence, we evaluated the latter associations of chemosensory dysfunction, in hospitalized COVID-19 patients in the United Arab Emirates (UAE). MATERIALS AND

METHODS:

Information on chemosensory dysfunction and history of chronic systemic comorbidities, if any, was obtained from 149 COVID-19 patients in an infectious disease hospital in UAE, using their medical records, as well as from a face-to-face questionnaire survey. Additionally, a modified SNOT-22 questionnaire that measures disease-specific quality of life in patients with upper respiratory tract affections was also administered.

RESULTS:

Chemosensory dysfunction was reported by 94.6% of the cohort, and anosmia with dysgeusia was significantly more in males than females with severe COVID-19. Males with moderate COVID-19 and systemic comorbidities were more likely to present with chemosensory dysfunction in comparison with females. SNOT-22 questionnaire revealed that nasal blockage and runny nose were more prevalent in mild/moderate, than in the severe, state of COVID-19.

CONCLUSION:

Our data confirm the commonality of chemosensory dysfunction during COVID-19 progression, and the significantly more pronounced combined dysfunction in males with severe COVID-19, and comorbidities.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Qualitative research Topics: Long Covid Limits: Female / Humans / Male Country/Region as subject: Asia Language: English Journal: Oral Dis Journal subject: Dentistry Year: 2022 Document Type: Article Affiliation country: Odi.13713

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Qualitative research Topics: Long Covid Limits: Female / Humans / Male Country/Region as subject: Asia Language: English Journal: Oral Dis Journal subject: Dentistry Year: 2022 Document Type: Article Affiliation country: Odi.13713